Blogs about: Denosumab
Featured Blog
Is denosumab "better" than Zometa at preventing skeletal events?
Amgen, the developer of denosumab (also known as RANK-L) has released data today from a head-to-head trial of their drug vs. zoledronate (Zometa) in the management of patients with advanced breast can… more →
THE "NEW" PROSTATE CANCER INFOLINK
Denosumab demonstrates superiority over zoledronic acid in patients with advanced breast cancer
associazionegender wrote 4 days ago: Denosumab versus zoledronic acid in the treatment of bone metastases in 2,049 patients with advanced … more →
Is denosumab "better" than Zometa at preventing skeletal events?
Sitemaster wrote 1 week ago: Amgen, the developer of denosumab (also known as RANK-L) has released data today from a head-to-head … more →
AUA report and update no. 2: Sunday, April 26, 2009
Sitemaster wrote 2 months ago: Two important papers presented this afternoon addressed data on the use of toremifene and denosumab … more →
The Thursday news reports: March 19, 2009
Sitemaster wrote 4 months ago: There are six new reports in today’s news, of which the most immediately important would seem … more →
Thursday's news reports: February 19, 2009
Sitemaster wrote 4 months ago: Today’s important news reports address: 5- and 7-year survival data following iodine-125 perm … more →
The Power of Appreciation
— 2 comments
RivkA (Coffee and Chemo) wrote 6 months ago: (cross posted from Coffee and Chemo) Last week, I was due to receive all three of my treatments on H … more →
Denosumab (AMG 162) for Treatment of Breast Cancer with Bone Metastases
bmirtsching wrote 1 year ago: Receptor activator of NF-B ligand (RANKL) is a key mediator of osteoclast (bone dissolving cells) fo … more →
Have your say. Start a blog.
See our free features →
An 
Brainchild
